ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Impact of Multimodality Treatment Sequence on Survival in Stage IIB Non-Small Cell Lung Cancer
Friday, December 10, 2021
Submitted by
Source
Source Name: The Annals of Thoracic Surgery
Source URL: https://doi.org/10.1016/j.athoracsur.2020.12.008
The wroth of neoadjuvant treatment in conjunction with resection as multimodality therapy (MMT) for stage IIB non-small cell lung cancer is still controversial.
Printer-friendly
